Fri.Sep 22, 2017

article thumbnail

Silicon Beach Report Sept. 22: Hyperloop One Raised $85 Million at a Valuation of More Than $700 Million

L.A. Business Journal

Hyperloop One raised $85 million at a valuation of more than $700 million, Faraday Future cuts loose its Nevada factory and incentives and Stratolaunch megaplane fires all six engines for the first time.

Report 113
article thumbnail

Plenty of Fish Connects With Google Home

socalTECH

Plenty of Fish (POF), the online dating company owned by Match.com--and run out of Los Angeles--says it has integrated its dating services with Google Assistant, running on Google Home, Android devices, and iPhones. According to Plenty of Fish, the integration allows users to ask Google Assistant if they have new messages on the dating services, and will read those messages aloud to the individual.

Google 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Machines Understand Text - NLP, Machine Learning in Practice

SoCal Tech Calendar

Thursday, September 28, 2017 -- How Machines Understand Text - NLP, Machine Learning in Practice. We have a great session planned that will use two case studies of Natural Language Processing and Machine Learning to explore opportunities that businesses have with understanding text. Come join us for a moderated session led by Dr. Jon Morra as he guides us through in depth use cases of NLP and their applications in predictive analytics.

article thumbnail

Hyperloop One Raises $85M More

socalTECH

Los Angeles-based Hyperloop One , which is building high speed, Hyperloop transportation systems, says it has raised $85M in a Series B-1 funding round. The funding brings the company's total raised to $245M since it was founded in 2014. The new funding came from Caspian VC Partners (as part of Summa Group and OurCrowd.com), DP World, WTI, as well as the company's existing investors.

article thumbnail

Can You Ask for Office Rent Relief? How to Manage Your Lease During COVID-19

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

article thumbnail

Orange County VC and Angel Investor Conference

SoCal Tech Calendar

Thursday, September 28, 2017 -- Orange County VC and Angel Investor Conference. FundingPost. Interested in meeting and pitching to early-stage Angel Investors and Venture Capitalists in Orange County? Register for the FundingPost event on Thursday, September 28th, 2017. At our next event, the panel of investors will focus on Early-Stage Venture Investing: How to meet investors, pitch them, and what it really takes to get them to write you a check!

article thumbnail

AfterNow Releases AR Tool For Filmmakers

socalTECH

Culver City-based AfterNow said this week that it has released a new application, Blocker , which helps filmmakers take advantage of Apple's ARKit. AfterNow said that the tool lets a director place virtual characters in an augmented reality environment, for blocking or storyboarding. AfterNow said the tool is aimed at helping filmmakers to accurately prepare scenes to communicate positioning of cameras and characters.

Tool 100

More Trending

article thumbnail

8 Coaching Myths To Avoid In Building Your Team

Startup Professionals Musings

Business productivity is all about having the right people, even though I’m bombarded daily with online tools and mobile apps that promise to solve every problem with automation and data. In reality, business success and satisfaction is about doing the right things at the right time, which requires leadership and coaching. But coaching doesn’t always work the way you expect.

Coach 57
article thumbnail

Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More

Xconomy

It’s been a year of biomedical milestones in the U.S., including the first approval of a CAR-T cellular immunotherapy , the first smartphone app to treat substance abuse , and the first approval of a cancer drug based on genetic signature instead of the tumor’s organ of origin. Add to the list the first successful Phase 3 trial for an RNA interference drug, likely leading to a first ever FDA review.